Journals / Van Tıp Dergisi / 2018 / Cilt: 25 - Sayı: 2

Prothrombin G20210A and Factor V Leiden Mutations in Ischemic Arterial Stroke

İskemik Arteriyel İnmede Protrombin G20210A ve Faktör V Leiden Mutasyonları

Pages
132–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Exploring those mutations in the arteriel stroke cases and the high risk groups for stroke might be important to assess risk and manage the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ischemic stroke remains an important public health problem all over world.
📊
Key Findings & Data:It is well known that, some type of genetic mutations such as factor V Leiden and prothrombin G20210A contribute to the risk of ischemic venous stroke.
💡
Conclusion & Impact:Exploring those mutations in the arteriel stroke cases and the high risk groups for stroke might be important to assess risk and manage the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Ischemic stroke remains an important public health problem all over world. It is well known that, some type of genetic mutations such as factor V Leiden and prothrombin G20210A contribute to the risk of ischemic venous stroke. However, the role of those genetic mutations in the risk of arteriel stroke is still controversial. The aim of this study is to investigate the possible association between the genetic mutations such as factor V Leiden and prothrombin G20210A and the risk of arterial ischemic stroke. Material and Methods: Sixty-three patient with ischemic arterial stroke and 25 age and sex matched controls were included in the study. Results: Prothrombin G20210A mutation, factor V Leiden mutation, hypertention, hyperlipidemia and hyperhomocysteinemia have been found significantly more frequent in patients’ group compared to the controls. With the multivariate analysis prothrombin G20210 mutation was found as an independent risk factor for ischemic arterial stroke. Factor V Leiden mutation was not an independent risk factor although it was seen more frequent in the ischemic arteriel stroke group. Conclusions: Genetic mutations such as factor V Leiden and especially prothrombin G20210A should be considered as genetic risk factors for stroke. Exploring those mutations in the arteriel stroke cases and the high risk groups for stroke might be important to assess risk and manage the disease.

Özet

Amaç: İskemik inme tüm dünyada önemli bir halk sağlığı sorunu olmaya devam etmektedir. Faktör V Leiden ve protrombin G20210A gibi bazı genetik mutasyonların iskemik venöz inme riskine katkıda bulunduğu bilinmektedir. Bununla birlikte, bu genetik mutasyonların arteriyel inme riskindeki rolü hala tartışmalıdır. Bu çalışmanın amacı, faktör V Leiden ve protrombin G20210A gibi genetik mutasyonlar ile arteriyel iskemik inme riski arasındaki olası ilişkiyi araştırmaktır. Gereç ve Yöntem: İskemik arteriyel inmeli 63 hasta ve 25 yaş ve cinsiyet yönünden benzer kontrol olgusu çalışmaya alındı. Bulgular: Protrombin G20210 mutasyonu, faktör V Leiden mutasyonu, hipertansiyon, hiperlipidemi ve hiperhomosisteinemi, kontrol grubuna kıyasla hasta grubunda belirgin olarak daha sık görüldü. Çok değişkenli analiz ile protrombin G20210A mutasyonu, iskemik arteriyel inme için bağımsız bir risk faktörü olarak bulundu. Faktör V Leiden mutasyonu ise iskemik arteriyel inme grubunda daha sık görülmesine rağmen, bağımsız bir risk faktörü değildi. Sonuç: Faktör V Leiden ve özellikle protrombin G20210A gibi genetik mutasyonlar inme için genetik risk faktörleri olarak düşünülmelidir. Arteriyel inme vakalarında ve inme için riskli gruplarda bu mutasyonları araştırmak, riski değerlendirmek ve hastalığı yönetmek için önemli olabilir.

🔖

Cite This Article

GÜNEŞ, H. N. (2018). Prothrombin G20210A and Factor V Leiden Mutations in Ischemic Arterial Stroke. Van Tıp Dergisi, Cilt: 25 - Sayı: 2, 132–137. https://ajindex.com/articles/334504

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kalpage HA, Sumathipala DS, Goonasekara HW, Dissanayake VH. A Study on Hereditary Thrombophilia and Stroke in a Cohort from Sri Lanka. J Stroke Cerebrovasc Dis 2016; 25(1): 102- 109. Ranellou K, Paraskeva A, Kyriazopoulos P, Batistatou A, Evangelou A, El-Aly M, et al. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study. Blood Coagul Fibrinolysis 2015; 26(4): 430-435. de Paula SA, Ribeiro DD, Carvalho M, Cardoso J, Dusse LM, Fernandes AP. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinolysis 2006; 17(4): 271-275.
  2. Lenicek KJ, Ethuranovic V, Bronic A, Coen Herak D, Mejaski-Bosnjak V, Zadro R. Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack. Croat Med J 2013; 54(4): 346-354.
  3. Mishra MN, Kalra R, Rohatgi S. Clinical profile, common thrombophilia markers and risk factors in 85 young Indian patients with arterial thrombosis. Sao Paulo Med J 2013; 131(6): 384-388.
  4. Dong J, Elmadhoun O, Ma X. Aetiological diagnosis of middle-aged and elderly cryptogenic ischaemic cerebral vascular disease. Neurol Res 2015; 37(8): 744-749. 7. Anjana RM, Lakshminarayanan S, Deepa M, Farooq S, Pradeepa R, Mohan V. Parental history of type 2 diabetes mellitus, metabolic syndrome, and cardiometabolic risk factors in Asian Indian adolescents. Metabolism 2009; 58(3): 344-350.
  5. Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995; 15(6): 783-785.
  6. Saadatnia M, Salehi M, Amini G, Seyyed Agha Miri N. The impact of prothrombin (G20210A) gene mutation on stroke in youths. ARYA Atheroscler 2012; 8(1): 9-11.
  7. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90(5): 1747-1750. Dostálová G, Bělohlávek J, Hlubocká Z, Bayerová K, Bobčiková P, Kvasnička T, et al. Multiple thrombophilia mutations as a possible cause of premature myocardial infarction. Wien Klin Wochenschr 2017; 129(13-14): 503-508.
  8. Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000; 31(12): 3067-3078
  9. Pirhoushiaran M, Ghasemi MR, Hami J, Zargari P, Sasan Nezhad P, Azarpazhooh MR, et al. The Associat